Диссертация (1141264), страница 21
Текст из файла (страница 21)
Ansari K. F. Synthesis and biological activity of some triazole-bearingbenzimidazole derivatives / K. F. Ansari, C. Lal // J. Serb. Chem. Soc. – 2009. –Vol. 44. – P. 1017.70. Ansari K. F. Synthesis, physicochemical properties and antimicrobialactivity of some new benzimidazole derivatives / K. F. Ansari, C. Lal // Eur. J.Med. Chem. – 2009. – Vol. 44. – P.
4028-4033.71. Ansari K. F. Synthesis and evaluation of some new benzimidazolederivatives as potential antimicrobial agents / K. F. Ansari, C. Lal // Eur. J. Med.Chem. – 2009. – Vol. 44. – P. 2294-2299.72. Argekar A. P. Simultaneous determination of mebendazole and pyrantelpamoate from tablets by high performance liquid chromatography-reverse phase(RP-HPLC) / A. P. Argekar, S. V. Raj, S.
U. Kapadia // Talanta. – 1997. – Vol. 44. –P. 1959-1965.73.Bansal Y. The theraheutic journey of benzimidazoles: A rewiew / Y.Bansal, O. Silakari // Bioorg. & Med. Chem. – 2012. – Vol. 20. – P. 6208-6236.74.Bansal S. Old class but new dimethoxy analogue of benzimidazole: abacterial topoisomerase I inhibitor / S. Bansal., U. Tawar., M. Singh et al.
// Int. J.Antimicrob. Agents. – 2010. – Vol. 35. – P. 186-190.75. Birnir B. Bicuculline , phenobarbitaland diazepam modulatespontaneous GABAA channels in rat hippocampal neurons / B. Birnir, M. Eghball,A. B. Everitt, P. W. Gage // Br. J. Pharmacol. – 2000. – Vol. 131 (4). – P. 695-704.14576. Boacker S.
Endogenous dynorphin in epileptogenesis and epilepsy:anticonvulsant net effect via kappa opioid receptors / S. Boacker, M. Sayyah, W.Wittmann et al. // Brain. – 2007. – Vol. 130 (4). – P. 1017-1028.77.BoianiM.Imidazoleandbenzimidazolederivativesaschemotherapeutic agents / M. Boiani, M. Gonzalez // Mini Rev. Med. Chem. –2005. – Vol.
5. – P. 409-424.78. British Pharmacopoeia 2009. London: H.M. Stationary Office, 2009.79. Bruchas M. R. Kinase cascades and ligand-directed signaling at thekappa opioid receptor / M. R.Bruchas, C. Chavkin // J. Psychopharm. – 2010. –Vol. 11 (2). – P. 137-147.80. Carlezon W. J. Kappa-opioid ligands in the study and treatment ofmood disorders / W. J.
Carlezon, C. Beguin, A. T. Knoll et al. // J. Pharmacol. Ther.– 2009. – Vol. 213 (3). – P. 334-343.81. Cirilli R. Development and validation of an enantioselective andchemoselective HPLC method using a Chiralpak IA column to simultaneouslyquantify (R)-(+)- and (S)-(−)-lansoprazole enantiomers and related impurities / R.Cirilli, et al. // Journal of Pharmaceutical and Biomedical Analysis.
– 2009. – Vol.50. – P. 9-14.82. Commiskey S. Butorphanol: Effects of a prototypical agonistantagonist analgesic on k-opioid receptors / S. Commiskey, L-W. Fan, I. K. Ho etal. // J. Pharmacol. Sci. – 2004. – Vol. 98. – P. 109-116.83.Dubey A. K.
Benzimidazoles in a wormy world / A. K. Dubey, P. K.Sanyal // Online Vet. J. – 2010. – Vol. 5. № 2. – P. 63.84. El-SherifZ.A.Reversed-phasehighperformanceliquidchromatographic method for the determination of lansoprazole, omeprazole andpantoprazole sodium sesquihydrate in presence of their acid-induced degradationproducts / Z. A. El-Sherif, A. O.
Mohamed, M. G. El-Bardicy, M. F. El-Tarras //Chem. Pharm. Bull. – 2006. – V.54. №6. – P. 814-818.14685. Ellison K. E. Management of arrhythmias in heart failure / K. E.Ellison, W. G. Stevenson, M. O. Sweeney, et al. // Congestive Heart Failure. –2003. – Vol. 9. № 2. – P. 91-99.86. European Pharmacopoeia, 5th edition. European Department for theQuality of Medicines. Strasbourg, France, 2005.87. Gazdag M. Selection of high-performance liquid chromatographicmethods in pharmaceutical analysis. IV.
Selection of most applicable separationsystem / M. Gazdag, G. Szepesi // J Chromatogr. – 1989. – Vol. 464. № 2. – P. 279288.88. Gazdag M. Selection of high-performance liquid chromatographicmethods in pharmaceutical analysis. I. Optimization for selectivity in reversedphase chromatography / M. Gazdag, G.
Szepesi, E. Szeleczki // J Chromatogr. –1988. – Vol. 454. – P. 83-94.89. Goker H. Synthesis and potent antimicrobial activity of some novel 2phenyl or methyl-4H-1-benzopyran-4-ones carrying amidinobenzimidazoles / H.Goker, D.
W. Boykin, S. Yildiz // Bioorg. Med. Chem. – 2005. – Vol. 13. – P. 17071714.90. GorogS.Areultravioletandvisiblespectroscopyandspectrophotometry obsolete methods in pharmaceutical analysis? / S. Gorog, M.Babjak, M. Gazdag, et al. // Acta Pharm Hung. – 1999. – Vol. 69. № 2. – P. 60-68.91. Gupta A. Real-time near-infrared monitoring of content uniformity,moisture content, compact density, tensile strength, and young's modulus of rollercompacted powder blends / A.
Gupta, G. E. Peck, R. W. Miller, et al. // Journal ofPharmaceutical Sciences. – 2005. – Vol. 94. № 7. – P. 1589-1597.92. HayamM.Lotfy.Validatedspectrophotometricmethodsforsimultaneous determination of omeprazole, tinidazole and doxycycline in theirternary mixture / H. M. Lotfy, M. A. Hegazy, S. Mowaka et al. // SpectrochimicaActa Part A: Molecular and Biomolecular Spectroscopy. – 2016. – Vol.
153. – P.321-332.14793. Huigens R. W. The chemical synthesis and antibiotic activity of adiverse library of 2-aminobenzimidazole small molecules against MRSA andmultidrug-resistant A. baumannii / R. W. Huigens, S. Reyes, C. S. Reed et al. //Bioorg. Med. Chem. – 2006. – Vol. 18. – P. 663.94. Kalinkova G. N. Infrared spectroscopy in pharmacy / G. N. Kalinkova// Vibrational Spectroscopy. – 1999.
– Vol. 19 (2). – P. 307-320.95. Kivell B. Kappa opioids and the modulation of pain / B. Kivell, T. E.Prisinzano // J. Psychopharm. – 2010. – Vol. 210. – P. 109-119.96.Kus C. Synthesis and antioxidant properties of some novelbenzimidazole derivatives on lipid peroxidation in the rat liver / C. Kus, G. AyhanKilcigil, B. C. Eke, M. Iscan // Arch. Pharm.
Res. – 2004. – Vol. 27. – P. 156.97.Kus C. Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives ofbenzimidazole class / C. Kus, G. Ayhan-Kilcigil, S. Ozbey et all // Bioorg. Med.Chem. – 2008. – Vol. 16. – P. 4294-4303.98. Lindon J. C. Directly coupled HPLC–NMR and HPLC–NMR–MS inpharmaceutical research and development / J. C.
Lindon, J. K. Nicholson, I. D.Wilson // Journal of chromatography B: Biomedical Sciences and Applications. –2000. – Vol. 748. №1. – P. 233- 258.99. Lough W.J., Wainer I.W. High Performance Liquid Chromatography:Fundamental principles and practice. / W.
J. Lough, I. W. Wainer. – UK.: Blackie,1996. – 99 p.100. Luypaert J. Near-infrared spectroscopy applications in pharmaceuticalanalysis / J. Luypaert, D. L. Massart, Y. Van der Hetden // Talanta. – 2007. – Vol.72. № 3. – P. 865-883.101. Mackenzie I. S. Quantitative NMR / I. S. Mackenzie, G.
Griffiths //Anal. Proc. – 1984. – Vol. 21. № 12. – P. 502-506.102. Marinissen M. J. G-protein-coupled receptors and signaling networks:emerging paradigms / M. J. Marinissen, J. S. Gutkind // Trends Pharmacol. Sci. –2001. – Vol. 22. – P. 368-376.148103. Michaud V. An improved HPLC assay with fluorescence detection forthe determination of domperidone and three major metabolites for application to invitro drug metabolism studies / V. Michaud, C. Simard, J. Turgeon // Journal ofChromatography B. – 2007. – Vol. 852.
– P. 611-616.104. Narasimhan B. Benzimidazole: a medical important heterocyclicmoiety / B. Narasimhan, D. Sharma, P. Kumar // Med. Chem. Res. – 2012. –Vol.21. – P. 269-283.105. Patil. A. A systematic review ofbenzimidazole derivatives as anantiulcer agent / A. Patil, S. Ganguly, Surana s. Rasayan // J. Chem. – 2008. – Vol.1. № 3.
– P. 447-460.106. Pflieger J. F. Picrotoxin and bicuculline have different effects onlumbar spinal networks and motoneurons in the neonatal rat / J. F. Pflieger, L.Clarac, L. Vinay // Brain Ress. – 2002. – Vol. 935 (1-2). – P. 81-86.107. Prisinzano T. E. k Opioids as potential treatments for stimulantdependence / T. E. Prisinzano, K. Tidgewell, W. W. Harding // Drug Addiction. –2008. – Vol.
2. – P. 231-245.108. Ries U. J. 6-Substituted benzimidazoles as new nonpeptide angiotensinII receptor antagonists: synthesis, biological activity, and structure-activityrelationships / U. J. Ries, G. Mihm, B. Narr et. All // J. Med. Chem. – 1993. – Vol.36. – P. 4040-4051.109. Sanahanbi N. Synthesis of schiff’s bases of 2-methyl benzimidazolederivatives and screening of analgesic and anti-inflammatory activities / N.Sanahanbi, T. Sivakumar // AJBPAD.
– 2013. – Vol. 4. – P. 487.110. Shukla.Synthesisandbiologicalscreeningof benzimidazolederivatives / Shukla // IJPSR. – 2012. – Vol. 3 (3). – P. 922-927.111. Siva Kumar B. V. Synthesis and anti-bacterial activity of some novel 2(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles / B. V. Siva Kumar,S.
D. Vaidya, R. V. Kumar et al. // Eur. J. Med. Chem. – 2006. – Vol. 41. – P. 599604.149112. Sivasubramanian L. Simultaneous HPLC estimation of omeprazole anddomperidone from tablets / L. Sivasubramanian, V. Anilkumar // Indian Journal ofPharmaceutical sciences. – 2007. – V. 69. № 5. – P. 674-676.113. Sluggett G. W.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
